The effect of oral antiplatelet agents on tissue plasminogen activator- mediated thrombolysis in a rabbit model of thromboembolic stroke

Neurosurgery

Volumn 39, Issue 2, 1996, Pages 352-359

  Bednar, Martin M ^a,c   Quilley, John ^b   Russell, Sheila R ^a   Fuller, Susan P ^a   Booth, Christina ^a   Howard, Diantha ^a   Gross, Cordell E ^a  

^a UNIVERSITY OF VERMONT COLLEGE OF MEDICINE   (United States)

^b NEW YORK MEDICAL COLLEGE   (United States)

^c UNIVERSITY OF VERMONT   (United States)

Author keywords

Antiplatelet; Aspirin; Stroke

Indexed keywords

ACETYLSALICYLIC ACID; ANTITHROMBOCYTIC AGENT; TICLOPIDINE; TISSUE PLASMINOGEN ACTIVATOR;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BLOOD CLOT LYSIS; BRAIN BLOOD FLOW; BRAIN INFARCTION; CONTROLLED STUDY; DOSE RESPONSE; DRUG EFFECT; DRUG EFFICACY; INTRAVENOUS DRUG ADMINISTRATION; NEUTROPHIL; NONHUMAN; OCCLUSIVE CEREBROVASCULAR DISEASE; PRIORITY JOURNAL; RABBITS AND HARES; STROKE; THROMBOCYTE AGGREGATION; THROMBOEMBOLISM; THROMBOGENICITY;

ANIMALS; ASPIRIN; BRAIN; CEREBROVASCULAR CIRCULATION; DOSE-RESPONSE RELATIONSHIP, DRUG; DRUG THERAPY, COMBINATION; FEMALE; INTRACRANIAL EMBOLISM AND THROMBOSIS; LEUKOCYTE COUNT; MALE; NEUTROPHILS; PLATELET AGGREGATION INHIBITORS; PLATELET COUNT; PREMEDICATION; RABBITS; THROMBOLYTIC THERAPY; TICLOPIDINE; TISSUE PLASMINOGEN ACTIVATOR;

EID: 0029984751     PISSN: 0148396X     EISSN: None     Source Type: Journal    
DOI: 10.1097/00006123-199608000-00024     Document Type: Article

References (41)

1. Albers GW: Role of ticlopidine for prevention of stroke. Stroke 23:912-916, 1992.
2. Bednar MM, Dooley RH, Zamani M, Howard DB, Gross CE: Neutrophil and platelet activity and quantification following delayed t-PA therapy in a rabbit model of thromboembolic stroke. J Thromb Thrombolysis 1:179-185, 1995.
3. Bednar MM, Fanburg JC, Anderson ML, Raymond SJ, Dooley RH, Gross CE: Comparison of tetrazolium dye with light microscopic evaluation in a rabbit model of acute cerebral ischemia. Neurol Res 16:129-132, 1994.
4. Bednar MM, McAuliffe T, Raymond S, Gross CE. Tissue plasminogen activator reduces brain injury in a rabbit model of thromboembolic stroke. Stroke 21:1705-1709, 1990.
5. Bednar MM, Raymond SJ, Gross CE: Tissue-plasminogen activator: Comparison of dose and route of administration in a rabbit model of thromboembolic stroke. Neutol Res 15:405-408, 1993.
6. Bednar MM, Raymond-Russell SJ, Booth CL, Gross CE: Combination tissue plasminogen activator and ticlopidine therapy in acute thromboembolic stroke. Neurol Res 18:45-48, 1996.
7. Buchanan MR, Hirsh J: Effect of aspirin on hemostasis and thrombosis. N Engl Regional Allergy Proc 7:26-31, 1986.
8. Chen J, Weinstein PR, Graham SH: Attenuation of postischemic brain hypoperfusion and reperfusion injury by the cyclooxygenase-lipoxygenase inhibitor BW755C. J Neurosurg 83:99-104, 1995.
9. Clark WM, Madden KP, Lyden PD, Zivin JA: Cerebral hemorrhagic risk of aspirin or heparin therapy with thrombolytic treatment in rabbits. Stroke 22:872-876, 1991.
10. Di Minno G, Cerbone AM, Mattioli PL, Turco S, lovine C: Functionally thrombasthenic state in normal platelets following the administration of ticlopidine. J Clin Invest 75:328-338, 1985.
11. Dyken ML, Barnett HJM, Easton JD, Fields WS, Fuster V, Hachinski V, Norris JW, Sherman DG: Low-dose aspirin and stroke: "It ain't necessarily so." Stroke 23:1395-1399, 1992.
12. FitzGerald GA, Oates JA, Hawiger J, Maas RL, Roberts LJ II, Lawson JA, Brash AR: Endogenous biosynthesis of prostacyclin and thromboxane and platelet function during chronic administration of aspirin in man. J Clin Invest 71:676-686, 1983.
13. Garcia JH: The evolution of brain infarcts: A review. J Neuropathol Exp Neurol 51:387-393, 1992.
14. Gross CE, Bednar MM, Howard DB, Sporn MB: Transforming growth factor-1 reduces infarct size after experimental cerebral ischemia in a rabbit model. Stroke 24:558-562, 1993.
15. Gross CE, Howard DB, Dooley RH, Raymond SJ, Fuller S, Bednar MM: TGF-β1 post-treatment in a rabbit model of cerebral ischemia. Neurol Res 16:465-470, 1994.
16. Gross CE, Raymond SR, Howard DB, Bednar MM: Delayed tissue plasminogen activator therapy in a rabbit model of thromboembolic stroke. Neurosurgery 36:1172-1177, 1995.
17. 2 indomethacin and heparin promote post-ischemic neuronal recovery in dogs. Ann Neurol 12:145-156, 1982.
18. Hass WK, Easton JD, Adams HP Jr, Pryse-Phillips W, Molony BA, Anderson S, Kamm B: A randomized trial comparing ticlopidine hydrochloride with aspirin for the prevention of stroke in high-risk patients. N Engl J Med 321:501-507, 1989.
19. Hsu CY, Faught RE Jr, Furlan AJ, Coull BM, Huang DC, Hogan EL, Linet OI, Yatsu FM: Intravenous prostacyclin in acute non-hemorrhagic stroke: A placebo-controlled double-blind trial. Stroke 18:352-358, 1987.
20. Jones TH, Morawetz RB, Crowell RM, Marcoux FW, Fitzgibbon SJ, DeGirolami U, Ojemann RG: Thresholds of focal cerebral ischemia in awake monkeys. J Neurosurg 54:773-782, 1981.
21. Kohut JJ, Bednar MM, Kimelberg JK, McAuliffe TL, Gross CE: Reduction in ischemic brain injury by the anion transport inhibitor L644,711. Stroke 23:93-97, 1992.
22. Lagarde M, Ghazi I, Dechavanne M: Effects of ticlopidine on platelet prostaglandin metabolism: Possible consequences for prostacyclin production. Prostaglandins Med 2:433-440, 1979.
23. Lam JYT, Chesebro JH, Steele PM, Harris M, Badimon L, Fuster V: Antithrombotic therapy for arterial injury by angioplasty: Efficacy of common platelet inhibitors versus thrombin inhibition in pigs. Circulation 84:814-820, 1991.
24. Levin RI, Harpel PC, Weil D, Chang T-S, Rifkin DB: Aspirin inhibits vascular plasminogen activator activity in vivo: Studies utilizing a new assay to quantify plasminogen activator activity. J Clin Invest 74:571-580, 1984.
25. Levine SR, Brott TG: Thrombolytic therapy in cerebrovascular disorders. Prog Cardiovasc Dis 34:235-262, 1992.
26. Lin TN, He YY, Wu G, Khan M, Hsu CY: Effect of brain edema on infarct volume in a focal cerebral ischemia model in rats. Stroke 24:117-121, 1993.
27. Overgaard K: Thrombolytic therapy in experimental embolic stroke. Cerebrovasc Brain Metab Rev 6:257-286, 1994.
28. Overgaard K, Sereghy T, Pedersen H, Boysen G: Dose-response of rt-PA and its combination with aspirin in a rat embolic stroke model. Clin Neurosci Neuropathol 3:925-928, 1992.
29. Overgaard K, Sereghy T, Pedersen H, Boysen G: Effect of delayed thrombolysis with rt-PA in a rat embolic stroke model. J Cereb Blood Flow Metab 14:472-477, 1994.
30. Quilley J, McGiff JC: Arachidonic acid metabolism and urinary excretion of prostaglandins and thromboxane in rats with experimental diabetes mellitus. J Pharmacol Exp Ther 234:211-216, 1985.
31. Ridenour TR, Warner DS, Todd MM, Baker MT: Effects of ketamine on outcome from temporary middle cerebral artery occlusion in the spontaneously hypertensive rat. Brain Res 565:116-122, 1991.
32. Saltiel E, Ward A: Ticlopidine: A review of its pharmacodynamic and pharmacokinetic properties, and therapeutic efficacy in platelet-dependent disease states. Drugs 34:222-262, 1987.
33. Thomas GR, Thibodeaux H, Bennett WF, Refino CJ, Badillo JM, Errett CJ, Zivin JA: Optimized thrombolysis of cerebral clots with tissue-type plasminogen activator in a rabbit model of embolic stroke. J Pharmacol Exp Ther 264;67-73, 1993.
34. Thomas GR, Thibodeaux H, Errett CJ, Bednar MM, Gross CE, Bennett WR: Intravenous aspirin causes a paradoxical attenuation of cerebrovascular thrombolysis. Stroke 26:1039-1046, 1995.
35. Uchiyama S, Yamazaki M, Maruyama S, Handa M, Ikeda Y, Fukuyama M, Itagaki I: Shear-induced platelet aggregation in cerebral ischemia. Stroke 25:1547-1551, 1994.
36. 2 receptor antagonist, vapiprost, in a rat middle cerebral artery thrombosis model. Stroke 24:1077-1082, 1993.
37. Vane JR: Inhibition of prostaglandin synthesis as a mechanism of action for aspirin-like drugs. Nature New Biol 231:232-235, 1971.
38. Deleted in proof.
39. Wardlaw JM, Warlow CP: Thrombolysis in acute ischemic stroke: Does it work? Stroke 23:1826-1839, 1992.
40. Wilson JT, Bednar MM, McAuliffe TL, Raymond S, Gross CE: The effect of the 21-aminosteroid U74006F in a rabbit model of thromboembolic stroke. Neurosurgery 31:929-934, 1992.
41. Young W: Hydrogen clearance measurement of blood flow: A review of technique and polarographic principles. Stroke 11:552-564, 1980.